World's Best Scientists 2026 revealed!
Francesco Paolo Schena

Francesco Paolo Schena

D-Index & Metrics

Medicine

D-Index
89
Citations
27466
World Ranking
12751
National Ranking
486

Francesco Paolo Schena publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Francesco Paolo Schena sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 482 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Francesco Paolo Schena D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Paolo Schena sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Francesco Paolo Schena is affiliated with the University of Bari Aldo Moro in Italy and is active in the field of medicine, with a strong focus on nephrology. Their research spans various related subfields, including hematology, pathology and forensic medicine, food science, and pulmonary and respiratory medicine.

The primary topics of their research include:

  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Systemic Sclerosis and Related Diseases
  • Platelet Disorders and Treatments
  • Dialysis and Renal Disease Management
  • Diabetes Treatment and Management
  • Renal Transplantation Outcomes and Treatments

Frequent venues for their publications reflect their research focus, with contributions appearing predominantly in:

  • Journal of the American Society of Nephrology
  • Journal of Nephrology
  • Clinical Kidney Journal
  • Nature Medicine
  • Kidney International

Frequent collaborators in their research include Daniela Isabel Abbrescia, Carlo Manno, Μaria Stangou, Tommaso Di Noia, and Sharon Natasha Cox, with collaboration counts ranging from 10 to 13 joint works.

Among their recent publications, key papers include:

  • "Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy," 2020, Kidney International
  • "A meta-analysis of GFR slope as a surrogate endpoint for kidney failure," 2023, Nature Medicine
  • "Immunosuppressive agents for treating IgA nephropathy," 2020, Cochrane Database of Systematic Reviews
  • "Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis," 2021, American Journal of Kidney Diseases
  • "Oleogelation of extra virgin olive oil by different oleogelators affects the physical properties and the stability of bioactive compounds," 2021, Food Chemistry

Best Publications

  • Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

    Stallone G;Schena A;Infante B;Di Paolo S

  • Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

    Piero Ruggenenti;Annalisa Perna;Giulia Gherardi;Giovanni Garini

  • Pathogenetic Mechanisms of Diabetic Nephropathy

    Francesco P. Schena;Loreto Gesualdo

  • Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

    Francesco P. Schena;Michael D. Pascoe;Josefina Alberu;Maria del Carmen Rial

  • Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

    Jürgen Floege;Thomas Rauen;Frank Eitner

  • Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

    Giovanni F M Strippoli;Maria Craig;Jonathan J Deeks;Francesco Paolo Schena

  • Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy

    Carlo Manno;Giovanni F.M. Strippoli;Giovanni F.M. Strippoli;Loredana Arnesano;Loredana Arnesano;Carmen Bonifati;Carmen Bonifati

  • A retrospective analysis of the natural history of primary IgA nephropathy worldwide

    Schena Fp

  • Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy

    Carlo Manno;Diletta Domenica Torres;Michele Rossini;Francesco Pesce

  • Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma

    Tomohide Tatsumi;Lisa S. Kierstead;Elena Ranieri;Elena Ranieri;Loreto Gesualdo

  • The number, quality, and coverage of randomized controlled trials in nephrology.

    Giovanni F M Strippoli;Jonathan C Craig;Francesco P Schena

  • A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

    F. Vincenti;F. P. Schena;S. Paraskevas;I. A. Hauser

  • Long-Term Benefits with Sirolimus-Based Therapy after Early Cyclosporine Withdrawal

    Henri Kreis;Rainer Oberbauer;Josep M. Campistol;Timothy Mathew

  • The Italian experience of the national registry of renal biopsies

    Loreto Gesualdo;Anna Maria Di Palma;Luigi Francesco Morrone;Giovanni Fabrizio Strippoli

  • Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology.

    F P Schena

  • Epidemiology of IgA Nephropathy: A Global Perspective.

    Francesco Paolo Schena;Ionut Nistor

  • Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura.

    R. Coppo;G. Mazzucco;L. Cagnoli;Antonio Lupo

  • Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease

    Simona Granata;Gianluigi Zaza;Simona Simone;Gaetano Villani

  • Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Hiddo J L Heerspink;Tom Greene;Hocine Tighiouart;Hocine Tighiouart;Ron T Gansevoort

  • Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial

    C. Ponticelli;A. Edefonti;L. Ghio;G. Rizzoni

Frequent Co-Authors

Loreto Gesualdo
Loreto Gesualdo University of Bari Aldo Moro
Giovanni F.M. Strippoli
Giovanni F.M. Strippoli University of Sydney
Elena Ranieri
Elena Ranieri University of Foggia
Jonathan C. Craig
Jonathan C. Craig Flinders University
Francesco P. Fanizzi
Francesco P. Fanizzi University of Salento
Antonio Amoroso
Antonio Amoroso University of Turin
Yasuhiko Tomino
Yasuhiko Tomino Juntendo University
Jürgen Floege
Jürgen Floege RWTH Aachen University
Allison Tong
Allison Tong University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in a medical career but seeking flexible or alternative pathways? The growing field of online healthcare education offers many options to diversify your expertise and advance your career—all while studying from home.

For those looking to enter nursing quickly, some absn programs that don't require teas exams offer an accelerated route without extra standardized testing barriers. Already a registered nurse? Consider bridging to advanced practice with reputable rn to np programs, which streamline the process of becoming a nurse practitioner.

If administration is more your interest, check out a healthcare administration accelerated degree. These programs equip you for leadership roles in hospitals, clinics, or public health organizations. Meanwhile, for those passionate about food science and patient well-being, pursuing a bachelor's in nutrition online can unlock opportunities in clinical, research, or wellness settings.

Exploring these online and bridge programs can provide a valuable foundation for anyone pursuing a dynamic and impactful career in medicine or healthcare.

Best Scientists Citing Francesco Paolo Schena

Trending Scientists

Recently Published Articles